“…Subsequently, 10 studies were excluded for the following reasons: inclusion of pediatric cases (n=7) [20] , [21] , [22] , [23] , [24] , [25] , [26] , diagnosis of multisystem inflammatory syndrome (n=1) [27] , analysis of incidence data of a pharmacovigilance database (n=1) [28] and opinion paper (n=1) [29] . Therefore, 39 studies were included; 37 of them [30] , [31] , [32] , [33] , [34] , [35] , [36] , [37] , [38] , [39] , [40] , [41] , [42] , [43] , [44] , [45] , [46] , [47] , [48] , [49] , [50] , [51] , [52] , [53] , [54] , [55] , [56] , [57] , [58] , [59] , [60] , [61] , [62] , [63] , [64] , [65] , [66] provided individual data of 86 participants, forming the pooled cohort. On the other hand, 2 observational studies [67] , [68] reported aggregated data of 43 patients.…”